All Deals
April 23, 2026 - Deals
Leisure Hydration Secures Series A Funding Led By Midnight Venture Partners With Strategic Investors
Leisure Hydration closed an oversubscribed Series A round led by Midnight Venture Partners, with participation from beverage executives and strategic investors across the industry, as the functional hydration brand accelerates its push into the mainstream. The company said the capital will support team expansion, national retail growth, and a brand refresh as it scales distribution across major retailers including Target, Whole Foods Market, and HEB. Founded in 2022, Leisure has positioned itself in the “modern hydration” category and reported rapid growth driven by its electrolyte and functional ingredient-focused drinks. “We’ve seen incredible organic growth,” said Alex Michaelsen, Co-founder and CEO of Leisure Hydration, as the company looks to extend its momentum into 2026.
FOUNDERS: Alex Michaelsen & Steve Michaelsen
INVESTORS: Midnight Venture Partners, Doss Cunningham, Asahi Group Beverages & Innovation, LLC; Greg LaVecchia, Jordan Brown, Brian Goldberg, Döehler Group, Mike LaVitola & Brooke Baevsky
ROUND: Series A
HQ: Venice, California
#VentureCapital #LeisureHydration #AlexMichaelsen #SteveMichaelsen #TradedVC
More Deals
View All
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC